Nanobiosym is an American nanotechnology company based in Cambridge, Massachusetts.
At the annual meeting of the Clinton Global Initiative on September 30, 2015, Nanobiosym chairman Anita Goel announced the company's intention to deploy its Gene-RADAR genetic test "in Africa to stop Ebola and other infectious outbreaks."[1]
Nanobiosym paid $90,000 in 2020 to Ballard Partners' Brian Ballard and Dan Mcfaul to lobby the White House, the United States Department of Health and Human Services and the Overseas Private Investment Corporation on issues related to health and pharmaceuticals.[2]
On November 8, 2022, Nanobiosym received an Emergency Use Authorization (EUA) for a SARS-CoV-2 PCR test called "The Nano Test for COVID-19".[3]
Investors in Nanobiosym include:[6]
Lobbying firms hired by Nanobiosym include:
Webb, J. (2015, September 30). Nanobiosym’s Gene-RADAR® Unveiled as the “Next Frontier” in Healthcare Technology at the Clinton Global Initiative Annual Meeting. Business Wire. http://archive.today/2024.01.03-201152/https://www.businesswire.com/news/home/20150928006575/en/Nanobiosyms-Gene-RADAR®-Unveiled-as-the-‘Next-Frontier’-in-Healthcare-Technology-at-the-Clinton-Global-Initiative-Annual-Meeting ↩︎
Nanobiosym Diagnostics Lobbying Profile. (2023, July 24). OpenSecrets. https://www.opensecrets.org/federal-lobbying/clients/summary?cycle=2020&id=F307211 ↩︎ ↩︎
The Nano Test for COVID-19 EUA Summary. (2022, November 8). Food and Drug Administration. https://web.archive.org/web/20230511163446/https://www.fda.gov/media/163098/download#:~:text=The Nano Test for COVID-19 is a real-time,Nano-Saliva Collection Kit%2C when ↩︎
Team. Nanobiosym. Retrieved November 27, 2023, from http://archive.today/2023.11.27-044333/https://nanobiosym.com/our-team/ ↩︎
Anita Goel, MD, PhD. Taksha Institute. Retrieved November 27, 2023, from http://archive.today/2023.11.27-053732/https://www.taksha.org/advisors/goel/ ↩︎
Nanobiosym Company Profile: Valuation & Investors. PitchBook. Retrieved August 26, 2023, from http://archive.today/2023.08.27-062516/https://pitchbook.com/profiles/company/109455-31%23comparisons ↩︎
Experience | Dave Lopez. LinkedIn. Retrieved July 19, 2023, from http://archive.today/2023.07.19-225940/https://www.linkedin.com/in/dave-lopez-7b2306193/details/experience/ ↩︎
Nanobiosym. Tracxn. Retrieved August 27, 2023, from https://web.archive.org/web/20230827063851/https://tracxn.com/d/companies/nanobiosym/__M-7FbYsfk7_1TLvf4Lcn_XBP301Qg_AGvsX32hsouXY ↩︎
Nanobiosym – an Unreasonable company. Unreasonable Group. Retrieved August 27, 2023, from https://web.archive.org/web/20230827061727/https://unreasonablegroup.com/ventures/nanobiosym ↩︎
Senate Office of Public Records. Nanobiosym Inc Hired Firms. OpenSecrets. Retrieved August 29, 2023, from https://www.opensecrets.org/federal-lobbying/clients/hired-firms?cycle=2021&id=D000054092 ↩︎
Senate Office of Public Records. Nanobiosym Inc Hired Firms. OpenSecrets. Retrieved August 30, 2023, from https://web.archive.org/web/20230830021621/https://www.opensecrets.org/federal-lobbying/clients/hired-firms?cycle=2015&id=D000054092 ↩︎ ↩︎
Senate Office of Public Records. Nanobiosym Inc Hired Firms. OpenSecrets. Retrieved August 30, 2023, from https://web.archive.org/web/20230830021815/https://www.opensecrets.org/federal-lobbying/clients/hired-firms?cycle=2009&id=D000054092 ↩︎
Senate Office of Public Records. Nanobiosym Inc Hired Firms. OpenSecrets. Retrieved August 30, 2023, from http://archive.today/2023.08.30-021138/https://www.opensecrets.org/federal-lobbying/clients/hired-firms?cycle=2016&id=D000054092 ↩︎